← Leaderboards
Muayyad R Al-Ubaidi
University Of Houston
$6,623,740
Attributed
$10,169,114
Total exposure
11
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$10,169,114 · 11
By mechanism
R01$9,428,648 · 5
R21$431,750 · 1
P20$221,233 · 4
P30$87,483 · 1
Top collaborators
- Muna I Naash15 shared
Most similar at University Of Houston
Same institution · by research overlap
- Muna I Naash$18,005,875
- Larissa Ikelle$208,034
Others in their field
Top investigators on “Retina”
- Keri Hammel · The Emmes Company, Llc$53,700,408
- Krzysztof Palczewski · University Of California-Irvine$48,214,939
- Adam R Glassman · Jaeb Center For Health Research, Inc.$47,242,041
- Cecilia Sungmin Lee · University Of Washington$32,086,169
- Adam Glassman · Jaeb Center For Health Research, Inc.$31,583,813
- Karen J Cruickshanks · University Of Wisconsin Madison$28,499,261
Research focus
RetinaPhenotypeRetinal DegenerationBiochemicalProteinsRetinal DiseasesCellsMouse ModelPhotoreceptorsGenesRetinitis PigmentosaToxic EffectDefectBindingStructureStructure Of Retinal Pigment EpitheliumDoseEffective TherapyGenerationsMutationTechnologyMolecularTargeted TreatmentLead
Grant awards (31)
Mechanism of photoreceptor cell degeneration in animal models of retinal diseases$605,791
R01 · FY2025 · EY
Mutation-independent therapy for retinal degenerations caused by PRPH2 mutations$431,750
R21 · FY2025 · EY · contact PI
Mechanism of photoreceptor cell degeneration in animal models of retinal diseases$508,598
R01 · FY2024 · EY
Mechanism of photoreceptor cell degeneration in animal models of retinal diseases$508,598
R01 · FY2023 · EY
Supplement for: Mechanism of Photoreceptor Cell Degeneration in Animal Models of Retinal Diseases$114,651
R01 · FY2023 · EY
Mechanism of photoreceptor cell degeneration in animal models of retinal diseases$497,608
R01 · FY2022 · EY
Compacted DNA Nanoparticles for Ocular Therapy$548,089
R01 · FY2021 · EY
Mechanism of photoreceptor cell degeneration in animal models of retinal diseases$497,607
R01 · FY2021 · EY
Compacted DNA Nanoparticles for Ocular Therapy$565,038
R01 · FY2020 · EY
Mechanism of photoreceptor cell degeneration in animal models of retinal diseases$539,089
R01 · FY2020 · EY
Compacted DNA Nanoparticles for Ocular Therapy$565,038
R01 · FY2019 · EY
Role of retbindin in retinal homeostasis and diseases$382,500
R01 · FY2019 · EY
Compacted DNA Nanoparticles for Ocular Therapy$565,038
R01 · FY2018 · EY
Role of retbindin in retinal homeostasis and diseases$382,500
R01 · FY2018 · EY
Role of retbindin in retinal homeostasis and diseases$378,854
R01 · FY2017 · EY
Retinal degeneration caused by alterations in protein tyrosine O-sulfation$370,000
R01 · FY2013 · EY · contact PI
Retinal degeneration caused by alterations in protein O-sulfation$371,400
R01 · FY2010 · EY · contact PI
Retinal degeneration caused by alterations in protein O-sulfation$382,875
R01 · FY2009 · EY · contact PI
MOLECULAR BIOLOGY/FUNCTIONAL GENOMICS$118,927
P20 · FY2008 · RR · contact PI
FUNCTIONAL GENOMICS$31,433
P20 · FY2007 · RR · contact PI
RETINAL DEGENERATION: MOLECULAR AND BIOCHEMICAL ASPECTS$357,643
R01 · FY2006 · EY · contact PI
FUNCTIONAL GENOMICS$30,673
P20 · FY2006 · RR · contact PI
RETINAL DEGENERATION: MOLECULAR AND BIOCHEMICAL ASPECTS$410,748
R01 · FY2005 · EY
FUNCTIONAL GENOMICS$32,732
P20 · FY2005 · RR
RETINAL DEGENERATION: MOLECULAR AND BIOCHEMICAL ASPECTS$471,021
R01 · FY2004 · EY
FUNCTIONAL GENOMICS$7,468
P20 · FY2004 · RR
RETINAL DEGENERATION: MOLECULAR AND BIOCHEMICAL ASPECTS$366,250
R01 · FY2003 · EY
RETINAL DEGENERATION: MOLECULAR AND BIOCHEMICAL ASPECTS$39,712
R01 · FY2003 · EY
CORE--MOLECULAR BIOLOGY MODULE$0
P30 · FY2002 · EY
CORE--MOLECULAR BIOLOGY MODULE$0
P30 · FY2001 · EY
CORE--MOLECULAR BIOLOGY MODULE$87,483
P30 · FY2000 · EY